| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.00B | — |
| Operating expense | — | — |
| Net income | -1.48M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CRL returned +82.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +48.0% |
| 1 year | +82.4% |
| 5 years | -33.5% |
| 10 years | +254.8% |
| All-time high | $448.68 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CRL would be worth today ›No. Charles River Laboratories Inte has not paid a dividend in the past 12 months.
Charles River Laboratories Inte stock trades on NYSE under the ticker symbol CRL.
Charles River Laboratories Inte is part of the Healthcare sector.
Charles River Laboratories Inte has a market cap of 14.22B USD, based on the latest quote.
Charles River Laboratories Inte is expected to report earnings around Nov 4, 2026. That date is an estimate and has not been confirmed by the company.
